Search Page

1

Cite

Share

COVID-19 Pathogenesis: From Molecular Pathway to Vaccine Administration.

Nappi F, Iervolino A, Avtaar Singh SS. Nappi F, et al. Biomedicines. 2021 Jul 27;9(8):903. doi: 10.3390/biomedicines9080903. Biomedicines. 2021. PMID: 34440107 Free PMC article. Review.

Cite

Share

2

Cite

Share

Dysregulation in erythrocyte dynamics caused by SARS-CoV-2 infection: possible role in shuffling the homeostatic puzzle during COVID-19.

Mendonça MM, da Cruz KR, Pinheiro DDS, Moraes GCA, Ferreira PM, Ferreira-Neto ML, da Silva ES, Gonçalves RV, Pedrino GR, Fajemiroye JO, Xavier CH. Mendonça MM, et al. Hematol Transfus Cell Ther. 2022 Apr-Jun;44(2):235-245. doi: 10.1016/j.htct.2022.01.005. Epub 2022 Jan 25. Hematol Transfus Cell Ther. 2022. PMID: 35098037 Free PMC article. Review.

Cite

Share

3

Cite

Share

ASGARD: A Single-cell Guided pipeline to Aid Repurposing of Drugs.

He B, Garmire LX. He B, et al. ArXiv. 2021 Sep 14:arXiv:2109.06377v1. Preprint. ArXiv. 2021. PMID: 34545335 Free PMC article.

Cite

Share

4

Cite

Share

Exposure to sulfur mustard increases the risk for mortality in patients with COVID-19 infection: A cohort study.

Kolivand P, Fathi M, Kheyrati L, Lak M. Kolivand P, et al. Am J Emerg Med. 2022 Jan;51:144-149. doi: 10.1016/j.ajem.2021.09.053. Epub 2021 Sep 25. Am J Emerg Med. 2022. PMID: 34739867 Free PMC article.

Cite

Share

5

Cite

Share

Correction: Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.

PLOS ONE Staff. PLOS ONE Staff. PLoS One. 2021 May 13;16(5):e0251897. doi: 10.1371/journal.pone.0251897. eCollection 2021. PLoS One. 2021. PMID: 33984052 Free PMC article.

Cite

Share

6

Cite

Share

Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: A patient-level analysis of the PCORnet blood pressure control lab.

Smith SM, Desai RA, Walsh MG, Nilles EK, Shaw K, Smith M, Chamberlain AM, Derington CG, Bress AP, Chuang CH, Ford DE, Taylor BW, Chandaka S, Patel LP, McClay J, Priest E, Fuloria J, Doshi K, Ahmad FS, Viera AJ, Faulkner M, O'Brien EC, Pletcher MJ, Cooper-DeHoff RM. Smith SM, et al. Am Heart J Plus. 2022 Jan;13:100112. doi: 10.1016/j.ahjo.2022.100112. Epub 2022 Mar 2. Am Heart J Plus. 2022. PMID: 35252907 Free PMC article.

Cite

Share

7

Cite

Share

Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview.

Al-Karmalawy AA, Soltane R, Abo Elmaaty A, Tantawy MA, Antar SA, Yahya G, Chrouda A, Pashameah RA, Mustafa M, Abu Mraheil M, Mostafa A. Al-Karmalawy AA, et al. Vaccines (Basel). 2021 Nov 12;9(11):1317. doi: 10.3390/vaccines9111317. Vaccines (Basel). 2021. PMID: 34835248 Free PMC article. Review.

Cite

Share

8

Cite

Share

Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?

Hu Y, Liu L, Lu X. Hu Y, et al. Front Endocrinol (Lausanne). 2021 Oct 22;12:725967. doi: 10.3389/fendo.2021.725967. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34745001 Free PMC article. Review.

Cite

Share

9

Cite

Share

Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients.

Kulkarni PG, Sakharkar A, Banerjee T. Kulkarni PG, et al. Hypertens Res. 2022 Feb;45(2):254-269. doi: 10.1038/s41440-021-00800-4. Epub 2021 Nov 30. Hypertens Res. 2022. PMID: 34848886 Free PMC article. Review.

Cite

Share

10

Cite

Share

Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system.

Sandhu AT, Kohsaka S, Lin S, Woo CY, Goldstein MK, Heidenreich PA. Sandhu AT, et al. Am Heart J. 2021 Oct;240:46-57. doi: 10.1016/j.ahj.2021.06.004. Epub 2021 Jun 12. Am Heart J. 2021. PMID: 34126079 Free PMC article.

Cite

Share